Home > Drugs A – Z > Phendimetrazine (By mouth)

Phendimetrazine (By mouth)

Used with a diet plan for weight loss. This medicine is an appetite suppressant.

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Phendimetrazine is used as part of a short-term plan, along with a low calorie diet, for weight reduction. It is used in obese patients who have not been able to lose weight with diet and exercise alone. Phendimetrazine belongs to the group of medicines known as appetite suppressants. This medicine is available only with your doctor's prescription… Read more
Brand names include
Bontril, Bontril PDM, Bontril Slow-Release, Melfiat, Obezine, Phendiet, Phendiet-105, Prelu-2
Drug classes About this
Appetite Suppressant, Centrally Acting

What works? Research summarized

Evidence reviews

Drug Misuse: Psychosocial Interventions

This guideline has been developed to advise on psychosocial interventions for drug misuse. The guideline recommendations have been developed by a multidisciplinary team of healthcare professionals, service users, a carer and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high-quality care for people who misuse drugs while also emphasising the importance of the experience of care for people who misuse drugs and their carers.

Effectiveness of Weight Management Programs in Children and Adolescents

To examine available behavioral, pharmacological, and surgical weight management interventions for overweight (defined as BMI ≥ 85th to 94th percentile of age and sex-specific norms) and/or obese (BMI ≥ 95th percentile) children and adolescents in clinical and nonclinical community settings.

Effectiveness of Primary Care Interventions for Weight Management in Children and Adolescents: An Updated, Targeted Systematic Review for the USPSTF [Internet]

To examine behavioral and pharmacological weight management interventions for overweight (defined as BMI ≥ 85th to 94th percentile of age- and sex-specific norms) and/or obese (BMI ≥ 95th percentile) children and adolescents which are feasible to conduct in primary care settings or that may be available for referral from primary care in order to update an identified gap in the previous report on childhood obesity for the United States Preventive Services Task Force (USPSTF).

PubMed Health Blog...

read all...